(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 132.86% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.11%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Uniqure Nv's revenue in 2025 is $15,751,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2025 to be $1,144,235,558, with the lowest QURE revenue forecast at $416,918,100, and the highest QURE revenue forecast at $1,759,428,021. On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $3,766,589,987, with the lowest QURE revenue forecast at $647,085,795, and the highest QURE revenue forecast at $9,935,520,249.
In 2027, QURE is forecast to generate $14,024,345,008 in revenue, with the lowest revenue forecast at $6,683,895,440 and the highest revenue forecast at $23,502,021,533.